DRUGSwww.epgonline.orgDISEASE KNOWLEDGE CENTRESwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgMEDICAL NEWSwww.epgonline.orgLINKSwww.epgonline.org
Members Login
How to use the
Email

Password



EPG News Feed Medical News
EPG Online Disease Knowledge Centres Feed Disease Knowledge
Recent UK Drug Updates Drug Updates
EPG Search
Frequent Searches:
Search
Languages

Browse Other Languages
YouTube - Featured Content

Want to submit or suggest content for the epgonline.org YouTube Clinical channel?
Contact us here

epgonline.org is not responsible for content on any 3rd party website

(WHO) classifies chronic myeloid leukaemia (CML) as a myeloproliferative disease characterised by the presence of the Philadelphia chromosome (Ph) or the BCR-ABL fusion oncogene Clinical symptoms and signs of DVT are unreliable. DVT may present with pain, erythema, tenderness, and swelling of the affected limb. Alzheimer's disease (AD) is a progressive, neurodegenerative disease which will affect most of us at one point in time, and it’s prevalence increases with age. The prognosis of patients with diabetes is improved by interventions that reduce HbA1C
Are you a Doctor or Healthcare Professional? Authorise Viewing

Please register to access disease diagnosis, patient management, physician tools.

By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.

Change language Current language database: United Kingdom

A  |  B  |  C  |  D  |  E  |  F  |  G  |  H  |  I  |  J  |  K  |  L  |  M
N  |  O  |  P  |  Q  |  R  |  S  |  T  |  U  |  V  |  W  |  X  |  Y  |  Z

Medicine information : HERPID Topical Solution
 
Drug class description :  Thymidine analogues (antivirals).
Generic Name :  Idoxuridine, dimethyl sulfoxide (dimethyl sulphoxide)dimethyl sulphoxide
Drug description :  Topical SolutionSolution.
Presentation :  A clear, colourless solution containing idoxuridine BP 5% in dimethyl sulfoxide.
Indications :  Cutaneous herpes simplex and herpes zoster (shingles).
Adult Dosage :  Administration: Herpid should be painted on the lesions and their erythematous bases four times daily for four days. Adults: Treatment should start as soon as the condition has been diagnosed, ideally within two or three days after the rash appears. Good results are less likely if treatment is not started within seven days.
Child Dosage :  Children under 12 years: The use of Herpid in children with malignant disease might be justified but, although not a contra-indication, its use in children under the age of 12 years is not recommended.
Elderly Dosage :  No specific information on the use of this product in the elderly is available. Clinical trials have included patients over 65 years and no adverse reactions specific to this age group have been reported.
Contra Indications :  Known hypersensitivity to either idoxuridine or dimethyl sulfoxide. Dermographia.
Special Precautions :  Herpid in the eye causes stinging: treat by washing out with water. The dimethyl sulfoxide in Herpid may be irritant to the skin.
Interactions :  Since the solvent in Herpid can increase the absorption of many substances it is important that no other topical medication be used on the same areas of skin treated with Herpid. Pregnancy and lactation Animal studies have shown idoxuridine to be teratogenic. Consequently, Herpid should not be prescribed for women who are pregnant or at risk of becoming pregnant. In a small number of cases of women who used Herpid inadvertently in early pregnancy and who were followed to term, the infant was normal in each case.
Adverse Reactions :  Patients often experience stinging when applying Herpid and a distinctive taste during a course of treatment; both effects are transient. Skin reactions have occasionally been reported. Over-usage of the solution may lead to maceration of the skin.
Manufacturer :  Astellas Pharma
Drug Availability :  (POM)
Free registration to access disease diagnosis, patient management, physician tools.

Only registered users have access to the full EPG Online Knowledge Base including drug search tools, interactive disease Knowledge Centres via the EPG Knowledge Library - with clinical and evidence based physician and research tools, MiMedia (build your own clinical media collection with everything from key opinion leader essays to mode of action videos and other multi-media content), the EPG Survey panel, health news updates and much much more.

Already Registered?

Please log-in now using our member login box.

Not a member?

Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students.

Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major therapeutic areas, disease management, and clinical tools.

As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!

REGISTER today it only takes a minute! and it's FREE

Having problems?

Use our forgotten password facility or email us at: contact@epgonline.org

What's New!
Try EPG Mobile
Latest News
Disease Knowledge Centres

EPG Survey Become a member of
the new EPG Survey Panel.
Your opinions matter, get paid for them! Join Now!